Sign Up Today and Learn More About Micron Biomedical Stock
Invest in or calculate the value of your shares in Micron Biomedical or other pre-IPO companies through EquityZen's platform.
Micron Biomedical Stock (MICB)
Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.
About Micron Biomedical Stock
Founded
2014
Headquarters
Atlanta, GA, US
Industries
Science and Engineering, Health Care, Biotechnology
Micron Biomedical Press Mentions
Stay in the know about the latest news on Micron Biomedical
UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
globenewswire • Jan 14, 2025
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
globenewswire • Jan 14, 2025
CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19
globenewswire • Jan 08, 2025
Micron Biomedical Secures $43 Million
citybiz • Jan 08, 2025
Micron Biomedical Expands World-Renowned Advisory Team with Appointment of Medtech Innovation Leader, Sandeep Patel, PhD Ahead of Commercial Manufacturing of Its Needle-Free Technology
prnewswire • Sep 05, 2024
Micron Biomedical Management
Leadership team at Micron Biomedical
Co-Founder and Chief Scientific Officer
Mark Prausnitz
Join now and verify your accreditation status to gain access to:
- Micron Biomedical current valuation
- Micron Biomedical stock price
- Available deals in Micron Biomedical and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Micron Biomedical Stock
How to invest in Micron Biomedical stock?
Accredited investors can buy pre-IPO stock in companies like Micron Biomedical through EquityZen funds. These investments are made available by existing Micron Biomedical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Micron Biomedical stock?
Shareholders can sell their Micron Biomedical stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
